STAGE 1 RESULTS OF A 2-STAGE PHASE II TRIAL OF SINGLE AGENT AMRUBICIN IN PATIENTS WITH PREVIOUSLY TREATED THYMIC MALIGNANCIES

被引：0

作者：

Wakelee, Heather A. ^{[1
]}

Riess, Jonathan W. ^{[1
]}

San Pedro-Salcedo, Melanie ^{[1
]}

Padda, Sukhmani K. ^{[1
]}

Ramchandran, Kavitha ^{[1
]}

Gubens, Matthew A. ^{[2
]}

Neal, Joel W. ^{[1
]}

机构：

[1] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA

[2] UCSF, Div Hematol & Oncol, San Francisco, CA USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

chemotherapy; thymoma; Thymic carcinoma; amrubicin;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.24-048

引用

页码：S731 / S731

页数：1

共 50 条

[11] Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203 [J].

Tsukita, Yoko ;

Inoue, Akira ;

Sugawara, Shunichi ;

Kuyama, Shoichi ;

Nakagawa, Taku ;

Harada, Daijiro ;

Tanaka, Hisashi ;

Watanabe, Kana ;

Mori, Yoshiaki ;

Harada, Toshiyuki ;

Hino, Toshihiko ;

Fujii, Masanori ;

Ichinose, Masakazu .

LUNG CANCER, 2020, 139 :89-93

[12] Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium [J].

Spigel, David R. ;

Hainsworth, John D. ;

Shipley, Dianna L. ;

Mekhail, Tarek M. ;

Zubkus, John D. ;

Waterhouse, David M. ;

Daniel, Davey B. ;

Burris, Howard A., III ;

Greco, F. Anthony .

LUNG CANCER, 2018, 117 :38-43

[13] Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial [J].

Kim, J. H. ;

Kim, S. H. ;

Jeon, M. K. ;

Kim, J. E. ;

Kim, K. H. ;

Yun, K. -H. ;

Jeung, H. -C. ;

Rha, S. Y. ;

Ahn, J. -H. ;

Kim, H. S. .

ESMO OPEN, 2021, 6 (05)

[14] Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated stage IIIB/IV nonsmall cell lung carcinoma [J].

Socinski, MA ;

Sandler, AB ;

Israel, VK ;

Gillenwater, HH ;

Miller, LL ;

Locker, PK ;

Antonellini, A ;

Elfring, GL ;

Natale, RB .

CANCER, 2002, 95 (07) :1520-1527

[15] A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer [J].

Yoshioka, H. ;

Katakami, N. ;

Okamoto, H. ;

Iwamoto, Y. ;

Seto, T. ;

Takahashi, T. ;

Sunaga, N. ;

Kudoh, S. ;

Chikamori, K. ;

Harada, M. ;

Tanaka, H. ;

Saito, H. ;

Saka, H. ;

Takeda, K. ;

Nogami, N. ;

Masuda, N. ;

Harada, T. ;

Kitagawa, H. ;

Horio, H. ;

Yamanaka, T. ;

Fukuoka, M. ;

Yamamoto, N. ;

Nakagawa, K. .

ANNALS OF ONCOLOGY, 2017, 28 (02) :285-291

[16] Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma [J].

Galsky, Matthew D. ;

Hahn, Noah M. ;

Wong, Bryan ;

Lee, Karen M. ;

Argiriadi, Pamela ;

Albany, Costantine ;

Gimpel-Tetra, Kiev ;

Lowe, Nancy ;

Shahin, Mohamed ;

Patel, Vaibhav ;

Tsao, Che-Kai ;

Oh, William K. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) :1259-1265

[17] Phase 2 trial of the topoisomerase II inhibitor, amrubicin, as second-line therapy in patients with metastatic urothelial carcinoma [J].

Matthew D. Galsky ;

Noah M. Hahn ;

Bryan Wong ;

Karen M. Lee ;

Pamela Argiriadi ;

Costantine Albany ;

Kiev Gimpel-Tetra ;

Nancy Lowe ;

Mohamed Shahin ;

Vaibhav Patel ;

Che-Kai Tsao ;

William K. Oh .

Cancer Chemotherapy and Pharmacology, 2015, 76 :1259-1265

[18] Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia [J].

Kucuk, O ;

Kilton, L ;

Wade, JL ;

Blough, R ;

Benson, AB .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (04) :379-383

[19] A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines [J].

Vici, Patrizia ;

Di Lauro, Luigi ;

Sergi, Domenico ;

Foggi, Paolo ;

Viola, Giuditta ;

Mottolese, Marcella ;

Giotta, Francesco ;

Fattoruso, Silvia I. S. ;

Corsetti, Serena ;

Giannarelli, Diana ;

Botti, Claudio ;

Lopez, Massimo .

ONCOLOGY, 2008, 75 (3-4) :175-181

[20] Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial [J].

Besse, B. ;

Mazieres, J. ;

Ribassin-Majed, L. ;

Barlesi, F. ;

Bennouna, J. ;

Gervais, R. ;

Moreau, L. ;

Berard, H. ;

Debieuvre, D. ;

Molinier, O. ;

Moro-Sibilot, D. ;

Souquet, P. J. ;

Jacquot, S. ;

Petit, L. ;

Lena, H. ;

Pignon, J. P. ;

Lacas, B. ;

Morin, F. ;

Milleron, B. ;

Zalcman, G. ;

Soria, J. C. .

ANNALS OF ONCOLOGY, 2017, 28 (05) :1078-1083

← 1 2 3 4 5 →